pharma · Juvenile idiopathic arthritis · juvenile idiopathic arthritis
Alfasigma
Alfasigma S.p.A.
Alfasigma trial registry — 8 ClinicalTrials.gov studies with program phase, status, and indication context.
BOLOGNA, IT HQ
2,481 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- BOLOGNA, IT
- Employees
- 2,481
- Programs
- 8
- Drugs
- 8
- Patents
- 25
Alfasigma clinical trials
Registry index of 8 ClinicalTrials.gov studies linked to Alfasigma programs — each row shows trial ID, program name, phase, status, and indication.
Alfasigma trial registry — 8 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Alfasigma.
-
GS-US-417-0304 — Phase 3
Clinical update -
GLPG-0634-CL-131 — Phase 1
Clinical update -
VE-CIP1002/2021 — Phase 1
Clinical update -
GS-US-418-3899 — Phase 3
Clinical update -
GLPG0634-CL-333 — Phase 3
Clinical update -
GLPG0634-CL-331 — Phase 3
Clinical update -
GLPG0634-CL-329 — Phase 3
Clinical update -
Filgotinib — Phase 3
Clinical update